RIMARK-AM 5MG/2.5MG TABLET
By Rimark-AM
Rx
10 Tablet in a Strip

Composition
Amlodipine(5mg) + Ramipril(2.5mg)

Manufacturer - Lanark Laboratories Pvt Ltd
Lanark Laboratories Private Limited, Uchani, G.T. Road, Karnal-132001, Haryana, India

Expires on or after
August, 2025

liver
RIMARK-AM 5MG/2.5MG TABLET needs to be used carefully in individuals with liver disease. It may be necessary to adjust the dosage of RIMARK-AM 5MG/2.5MG TABLET for these patients, and it is crucial to consult your doctor before use. If any signs or symptoms of jaundice appear while taking this medication, promptly inform your doctor for further guidance.

kidney
RIMARK-AM 5MG/2.5MG TABLET must be used carefully in patients with kidney disease. Adjusting the dosage may be necessary; consult your doctor. Regular blood pressure monitoring is advised for proper dosing.

alcohol
It is not safe to consume alcohol while taking RIMARK-AM 5MG/2.5MG TABLET. It is advisable to avoid alcohol when using this medication to prevent any potential risks or interactions.

driving
When taking RIMARK-AM 5MG/2.5MG TABLET, be cautious while driving as it may cause side effects like dizziness, headaches, nausea, or tiredness. These symptoms could impact your ability to focus and drive safely.

pregnancy
RIMARK-AM 5MG/2.5MG TABLET is considered unsafe during pregnancy due to potential risks to the developing baby. However, in rare life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Consul with your doctor.

breastfeeding
Limited human studies indicate potential risk of RIMARK-AM 5MG/2.5MG TABLET passing into breastmilk, posing harm to the baby. It is likely unsafe during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹48
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025